That’s right I meant what I said in the title. I have been carping about the Medicare readmissions penalties since the program started and the research pretty much confirms how bad it is, including a recent analysis in the Journal of the American Medical Association, Internal Medicine. (JAMA Int. Med. Study) One of the conditions for which excessive readmissions are penalized is myocardial infarction or heart attack. The authors attempt to understand if there is a relationship between 30-day readmission performance and objective measures of care quality and long-term clinical outcomes. Over 176,000 patients at 380 hospitals. Smaller hospitals were generally excluded. CMS’ excess readmission rate was used for each of the hospitals. Standard process of care measure performance was evaluated via a pre-existing registry. Clinical outcomes included one-year all cause mortality or readmission. 43% of the hospitals had been deemed by CMS to have excessive readmissions. As other research has shown, there appeared to be demographic and health status factors that account for some of this performance, factors which CMS does not adjust for. In regard to most of the process of care measures, there was no difference in performance of hospitals across the readmission rate metric that CMS uses; i.e. there was no correlation. Following the initial 30-day period following discharge, there was no long-term risk association between the CMS readmission score and the clinical outcomes of mortality and readmission. Like all government bodies, CMS is stubborn as hell, believing in its own infallibility. It would be nice if it would dump or revise the program, but don’t expect it to recognize a mistake.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Two health care firms owned by private equity firms are merging in a transaction supposedly valued at $3 billion. HealthComp administers self-funded plans for employers and other groups and Virgin...
September 27, 2023
NextGen, an electronic medical records firm, is being put out of its public company misery, as a PE firm will pay $1.6 billion for the one-time high-flier.
September 7, 2023
A number of companies which attracted large financing rounds during the epidemic have imploded when reality set in. The latest is Cano Health, which is a little surprising since it...
August 15, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace